Is Attention Deficit Hyperactivity Disorder (ADHD) a “brain disorder”? Should it be managed regularly with stimulant drugs? This article critically examines the evolving biomedical discourse surrounding these questions through a close inspection of the latest edition of the influential psychiatric manual – the DSM-5-TR – as well as additional authoritative sources (e.g., previous DSM editions, consensus statements, FDA communications). The DSM-5-TR acknowledges that “no biological marker is…
